Free Trial

ReShape Lifesciences (RSLS) Competitors

ReShape Lifesciences logo
$2.38 -0.06 (-2.46%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$2.40 +0.02 (+0.63%)
As of 07/11/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RSLS vs. BIAF, ABT, ISRG, BSX, SYK, MDT, BDX, EW, IDXX, and RMD

Should you be buying ReShape Lifesciences stock or one of its competitors? The main competitors of ReShape Lifesciences include bioAffinity Technologies (BIAF), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), and ResMed (RMD). These companies are all part of the "medical" sector.

ReShape Lifesciences vs. Its Competitors

bioAffinity Technologies (NASDAQ:BIAF) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

In the previous week, bioAffinity Technologies had 2 more articles in the media than ReShape Lifesciences. MarketBeat recorded 3 mentions for bioAffinity Technologies and 1 mentions for ReShape Lifesciences. ReShape Lifesciences' average media sentiment score of 0.93 beat bioAffinity Technologies' score of 0.19 indicating that ReShape Lifesciences is being referred to more favorably in the news media.

Company Overall Sentiment
bioAffinity Technologies Neutral
ReShape Lifesciences Positive

ReShape Lifesciences has lower revenue, but higher earnings than bioAffinity Technologies. bioAffinity Technologies is trading at a lower price-to-earnings ratio than ReShape Lifesciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$9.36M0.93-$9.04M-$0.72-0.43
ReShape Lifesciences$7.18M0.79-$7.13M-$193.23-0.01

ReShape Lifesciences has a net margin of -48.26% compared to bioAffinity Technologies' net margin of -110.53%. ReShape Lifesciences' return on equity of -251.90% beat bioAffinity Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
bioAffinity Technologies-110.53% -367.64% -154.15%
ReShape Lifesciences -48.26%-251.90%-59.49%

bioAffinity Technologies has a beta of 2.52, meaning that its stock price is 152% more volatile than the S&P 500. Comparatively, ReShape Lifesciences has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500.

bioAffinity Technologies presently has a consensus price target of $6.00, suggesting a potential upside of 1,855.67%. Given bioAffinity Technologies' higher probable upside, equities research analysts clearly believe bioAffinity Technologies is more favorable than ReShape Lifesciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
bioAffinity Technologies
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
ReShape Lifesciences
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

1.6% of bioAffinity Technologies shares are held by institutional investors. Comparatively, 22.1% of ReShape Lifesciences shares are held by institutional investors. 16.9% of bioAffinity Technologies shares are held by insiders. Comparatively, 0.0% of ReShape Lifesciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

bioAffinity Technologies and ReShape Lifesciences tied by winning 7 of the 14 factors compared between the two stocks.

Get ReShape Lifesciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RSLS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RSLS vs. The Competition

MetricReShape LifesciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$5.68M$6.90B$5.61B$9.10B
Dividend YieldN/A1.25%5.24%4.00%
P/E Ratio-0.0126.3028.1820.27
Price / Sales0.7949.05428.6998.03
Price / CashN/A20.9237.4658.16
Price / Book-0.274.648.045.49
Net Income-$7.13M$174.76M$3.19B$250.45M
7 Day Performance-1.04%-1.00%3.62%4.79%
1 Month Performance-23.47%-1.49%4.06%7.68%
1 Year Performance-99.23%4.27%30.00%16.43%

ReShape Lifesciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RSLS
ReShape Lifesciences
0.3881 of 5 stars
$2.38
-2.5%
N/A-99.3%$5.68M$7.18M-0.0150Gap Down
BIAF
bioAffinity Technologies
1.3991 of 5 stars
$0.29
+7.6%
$6.00
+1,947.1%
-87.4%$7.75M$9.36M-0.4110Gap Up
ABT
Abbott Laboratories
4.9551 of 5 stars
$133.62
-0.6%
$142.61
+6.7%
+26.7%$233.90B$42.34B17.33114,000Trending News
Upcoming Earnings
Analyst Forecast
ISRG
Intuitive Surgical
4.6846 of 5 stars
$534.71
-1.8%
$588.95
+10.1%
+15.5%$195.15B$8.35B78.4015,638Positive News
Analyst Forecast
BSX
Boston Scientific
4.6592 of 5 stars
$103.75
-0.5%
$116.09
+11.9%
+34.2%$154.34B$16.75B75.7353,000Trending News
SYK
Stryker
4.8004 of 5 stars
$392.26
-0.8%
$427.30
+8.9%
+15.1%$150.87B$22.60B53.0153,000Positive News
Analyst Forecast
MDT
Medtronic
4.6187 of 5 stars
$87.73
-0.7%
$97.87
+11.6%
+15.3%$113.36B$33.54B24.2395,000Trending News
Analyst Forecast
Gap Up
BDX
Becton, Dickinson and Company
4.8168 of 5 stars
$172.92
-1.8%
$219.22
+26.8%
-21.8%$50.49B$20.87B33.0074,000Positive News
EW
Edwards Lifesciences
4.4662 of 5 stars
$76.64
-0.2%
$80.20
+4.6%
-15.9%$45.05B$5.44B10.9515,800News Coverage
Positive News
Analyst Forecast
IDXX
IDEXX Laboratories
3.5636 of 5 stars
$545.56
-0.3%
$558.11
+2.3%
+9.3%$43.99B$3.90B50.4211,000Positive News
Analyst Upgrade
RMD
ResMed
4.174 of 5 stars
$256.16
-0.3%
$259.33
+1.2%
+27.2%$37.68B$4.69B28.759,980Positive News
Insider Trade

Related Companies and Tools


This page (NASDAQ:RSLS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners